Anke Niedernberg
Corporate Officer/Principal bei ADVANZ PHARMA CORP. LIMITED
Profil
Anke Niedernberg is currently the Chief Transformation Officer at Advanz Pharma Corp.
Ltd.
She was previously a Partner at HgCapital Beratungs GmbH & Co. KG from 2008 to 2010.
Aktive Positionen von Anke Niedernberg
| Unternehmen | Position | Beginn |
|---|---|---|
| ADVANZ PHARMA CORP. LIMITED | Corporate Officer/Principal | 01.10.2021 |
Ehemalige bekannte Positionen von Anke Niedernberg
| Unternehmen | Position | Ende |
|---|---|---|
| HgCapital Beratungs GmbH & Co. KG | Private Equity Investor | 01.01.2010 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
| HgCapital Beratungs GmbH & Co. KG | Finance |
Advanz Pharma Corp. Ltd.
 Advanz Pharma Corp. Ltd. Pharmaceuticals: MajorHealth Technology ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom. | Health Technology |
